M J McLaughlin - JoVE Visualize

Showing results (31-40 of 43) with videos related to

Pageof 5

Sort By:

International Journal of Cancer|April 12, 2002

Tumor-targeted immune complex formation: effects on myeloid cell activation and tumor-directed immune cell migrationBart-Jan Kroesen, Pamela M J McLaughlin, Petra H L Schuilenga-Hut, et al.

Organic Letters|July 7, 2001

Stereoselective trans- and cis-dihydroxylations of 2H-pyranyl and dihydropyridinyl heterocycles synthesized from formal [3 + 3]-cycloaddition reactions of alpha,beta-unsaturated iminium ions with 1,3-dicarbonyl equivalentsL R Zehnder, L L Wei, R P Hsung, et al.

Nephron. Experimental Nephrology|November 21, 2007

Spatial and temporal expression patterns of the epithelial cell adhesion molecule (EpCAM/EGP-2) in developing and adult kidneysMonika Trzpis, Eliane R Popa, Pamela M J McLaughlin, et al.

Carcinogenesis|September 15, 2010

EpCAM in carcinogenesis: the good, the bad or the uglyBernardina T F van der Gun, Lieuwe J Melchers, Marcel H J Ruiters, et al.

Bioconjugate Chemistry|July 3, 2010

Targeted DNA methylation by a DNA methyltransferase coupled to a triple helix forming oligonucleotide to down-regulate the epithelial cell adhesion moleculeBernardina T F van der Gun, Maria Maluszynska-Hoffman, Antal Kiss, et al.

Molecular Carcinogenesis|December 23, 2006

Engineering zinc finger protein transcription factors to downregulate the epithelial glycoprotein-2 promoter as a novel anti-cancer treatmentWillemijn M Gommans, Pamela M J McLaughlin, Beatrice I Lindhout, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006

CD64-directed immunotoxin inhibits arthritis in a novel CD64 transgenic rat modelAnneke J van Vuuren, Joel A G van Roon, Vanessa Walraven, et al.

British Journal of Cancer|June 23, 2011

Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancerB T F van der Gun, M L de Groote, H G Kazemier, et al.

Cancer Gene Therapy|July 10, 2004

Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell linesPamela M J McLaughlin, Monika Trzpis, Bart-Jan Kroesen, et al.

BMC Cancer|May 6, 2022

Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III TrialPamela M J McLaughlin, Maximilian Klar, Tibor A Zwimpfer, et al.

Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:

Pageof 5

International Journal of Cancer|April 12, 2002

Tumor-targeted immune complex formation: effects on myeloid cell activation and tumor-directed immune cell migrationBart-Jan Kroesen, Pamela M J McLaughlin, Petra H L Schuilenga-Hut, et al.

Organic Letters|July 7, 2001

Stereoselective trans- and cis-dihydroxylations of 2H-pyranyl and dihydropyridinyl heterocycles synthesized from formal [3 + 3]-cycloaddition reactions of alpha,beta-unsaturated iminium ions with 1,3-dicarbonyl equivalentsL R Zehnder, L L Wei, R P Hsung, et al.

Nephron. Experimental Nephrology|November 21, 2007

Spatial and temporal expression patterns of the epithelial cell adhesion molecule (EpCAM/EGP-2) in developing and adult kidneysMonika Trzpis, Eliane R Popa, Pamela M J McLaughlin, et al.

Carcinogenesis|September 15, 2010

EpCAM in carcinogenesis: the good, the bad or the uglyBernardina T F van der Gun, Lieuwe J Melchers, Marcel H J Ruiters, et al.

Bioconjugate Chemistry|July 3, 2010

Targeted DNA methylation by a DNA methyltransferase coupled to a triple helix forming oligonucleotide to down-regulate the epithelial cell adhesion moleculeBernardina T F van der Gun, Maria Maluszynska-Hoffman, Antal Kiss, et al.

Molecular Carcinogenesis|December 23, 2006

Engineering zinc finger protein transcription factors to downregulate the epithelial glycoprotein-2 promoter as a novel anti-cancer treatmentWillemijn M Gommans, Pamela M J McLaughlin, Beatrice I Lindhout, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006

CD64-directed immunotoxin inhibits arthritis in a novel CD64 transgenic rat modelAnneke J van Vuuren, Joel A G van Roon, Vanessa Walraven, et al.

British Journal of Cancer|June 23, 2011

Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancerB T F van der Gun, M L de Groote, H G Kazemier, et al.

Cancer Gene Therapy|July 10, 2004

Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell linesPamela M J McLaughlin, Monika Trzpis, Bart-Jan Kroesen, et al.

BMC Cancer|May 6, 2022

Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III TrialPamela M J McLaughlin, Maximilian Klar, Tibor A Zwimpfer, et al.

Pageof 5